Nav: Home

'Connectosomes' create gateway for improved chemo delivery, fewer side effects

October 04, 2016

Engineering researchers at The University of Texas at Austin have developed a new method that delivers chemotherapy directly and efficiently to individual cells. The approach, described in the Sept. 8 edition of the Journal of the American Chemical Society, could provide a faster means of targeting and killing cancer cells with significantly lower doses of chemo than conventional drug delivery methods, which could decrease side effects for patients.

For this method, the researchers developed and utilized a new type of nanoparticles, which they call "connectosomes," that are equipped with gap junctions -- a pathway that allows for the rapid movement of molecules between two cells. The gap junctions allow the connectosomes to create a direct channel to deliver drugs to each individual cell.

The researchers believe their approach is a major step forward in realizing the advantages of nanoparticle-based drug delivery materials and improving the effectiveness of treatments.

Avinash Gadok, a doctoral student in the Cockrell School of Engineering, and biomedical engineering Assistant Professor Jeanne Stachowiak collaborated with Professor Hugh Smyth and postdoctoral fellow Silvia Ferrati, both from the College of Pharmacy at UT Austin, on the research.

According to their study, the team's new delivery method, which harnesses gap junctions to deliver chemotherapy directly and efficiently, has led to a significant decrease in the dose required to kill a cancer cell. Driving down the dosage of chemo could lessen potential side effects, from nausea and hair loss to infertility and heart damage, that patients experience. In addition, having a direct route to a cell could provide more effective treatment for later-stage tumors that have metastasized, which are often out of reach of current chemotherapy delivery methods.

"Gap junctions are the cells' mechanism for sharing small molecules between neighboring cells. We believed that there must be a way to utilize them for better drug delivery," Stachowiak said. "The big challenge was in making the materials efficiently and showing that the drugs are delivered through the gap junctions and not some other component."

To form the connectosomes, Gadok used a chemical process to derive liposomes from donor cells that were engineered to over-produce gap junctions, which are made of proteins. She then loaded the connectosomes with the chemotherapy drug doxorubicin.

The team's connectosomes address a main challenge in chemotherapeutics -- getting a concentrated dose of drugs to cross through the cell's plasma membrane barrier and reach its target inside of the cell.

Even highly membrane-permeable drugs, such as doxorubicin, have limited transport rates across the plasma membrane, so they require higher doses to be effective. And when the drug is freely delivered, doxorubicin kills healthy cells along with cancerous cells, resulting in harmful side effects.

In in-vitro tests with human cells, the researchers found that chemo delivered through connectosomes is 10 times as efficient at killing cancer cells as freely delivered doxorubicin. Connectosomes are also 100 to 100,000 times as efficient as conventional nanoparticles in delivering chemo, because a drug can diffuse more efficiently through a gap junction than across the oily lipid membrane.

"Connectosomes could open doors for the improved utilization of nanoparticles to deliver other types of therapies," Gadok said. "A huge advantage of nanoparticles is that they can target cells, which helps protect off-target tissues."

In two related projects, the researchers are seeing whether connectosomes can biochemically target tumor cells, and they are also researching to see whether they could be useful in inhibiting the migration of tumor cells. In particular, gap junctions are known to suppress cell migration, creating the potential for connectosomes to help control the movement of tumor cells out of the tumor and into the bloodstream.

"We would like to see whether this approach could delay metastasis while treating the tumor," Stachowiak said. "It would be nice to have a multipronged approach where you have a particle that slows down metastasis, rapidly delivers drugs and turns off expression of genes that are promoting the migration of tumor cells."
-end-
This research received funding from the National Science Foundation, the National Institutes of Health and Texas 4000 for Cancer, a charitable organization.

University of Texas at Austin

Related Nanoparticles Articles:

Chemists perform surgery on nanoparticles
A team of chemists led by Carnegie Mellon's Rongchao Jin has for the first time conducted site-specific surgery on a nanoparticle.
Nanoparticles remain unpredictable
The way that nanoparticles behave in the environment is extremely complex.
Gold standards for nanoparticles
KAUST researchers reveal how small organic 'citrate' ions can stabilize gold nanoparticles, assisting research on the structures' potential.
Lipid nanoparticles for gene therapy
Twenty-five years have passed since the publication of the first work on solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as a system for delivering drugs.
Nanoparticles hitchhiking their way along strands of hair
In shampoo ads, hair always looks like a shiny, smooth surface.
Better contrast agents based on nanoparticles
Scientists at the University of Basel have developed nanoparticles which can serve as efficient contrast agents for magnetic resonance imaging.
Gentle cancer treatment using nanoparticles works
Cancer treatments based on laser irridation of tiny nanoparticles that are injected directly into the cancer tumor are working and can destroy the cancer from within.
Radiation-guided nanoparticles zero in on metastatic cancer
Zap a tumor with radiation to trigger expression of a molecule, then attack that molecule with a drug-loaded nanoparticle.
Nanoparticles can grow in cubic shape
Use of nanoparticles in many applications, e.g. for catalysis, relies on the surface area of the particles.
Nanoparticles deliver anticancer cluster bombs
Scientists have devised a triple-stage 'cluster bomb' system for delivering the chemotherapy drug cisplatin, via tiny nanoparticles designed to break up when they reach a tumor.

Related Nanoparticles Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...